Friday, 6 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Update

Supriya Lifescience Results Update

Supriya Lifescience's Q2 FY27 revenue rose 3.2%, but EBITDA and PAT fell sharply. Ambernath ramp-up costs and LATAM regulatory shifts hurt margins.

Source

NSE filing, NSE: SUPRIYA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Supriya Lifescience Ltd: key numbers

Share price
₹695.70
Market cap
₹5,599 Cr
Revenue (annual)
₹827.9 Cr
Net profit (annual)
₹209.1 Cr
P/E (TTM)
31.6×Sector 42.0×
Promoter holding
68.30%+0.00% QoQ
FII holding
6.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Supriya Lifescience Ltd

All →

Other results update announcements

All →